Discussion: Redefining intensive LDL-c management in high CV risk patients - The case for combination therapy
Watch the discussion by the expert faculty of the symposium, chaired by prof. John Kastelein, Amsterdam, The Netherlands and speakers prof. Kausik Ray, London, UK, Derek Connolly, Birmingham, UK and prof. Christie Ballantyne, Houston, TX, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants received from Amgen, Sanofi, Novartis and Daiichi Sankyo.